Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience

The emerging outbreak of the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread worldwide. We prescribed some promising medication to our patients with mild to moderate pneumonia due to SARS-CoV-2, however such drugs as...

Descripción completa

Detalles Bibliográficos
Autores principales: Tascini, Carlo, Sermann, Giovanni, Pagotto, Alberto, Sozio, Emanuela, De Carlo, Chiara, Giacinta, Alessandro, Sbrana, Francesco, Ripoli, Andrea, Castaldo, Nadia, Merelli, Maria, Cadeo, Barbara, Macor, Cristiana, De Monte, Amato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Im - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603641/
https://www.ncbi.nlm.nih.gov/pubmed/33131033
http://dx.doi.org/10.1007/s11739-020-02542-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603641/
https://www.ncbi.nlm.nih.gov/pubmed/33131033
http://dx.doi.org/10.1007/s11739-020-02542-6

Ejemplares similares